Tumor necrosis factor is a therapeutic target for immunological unbalance and cardiac abnormalities in chronic experimental chagas' heart disease

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Pereira, Isabela Resende ^a   Vilar Pereira, Glaucia ^a   Silva, Andrea Alice ^b   Moreira, Otacilio Cruz ^a   Britto, Constança ^a   Sarmento, Ellen Diana Marinho ^a   Lannes Vieira, Joseli ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INFLIXIMAB; INTERLEUKIN 10; INTERLEUKIN 17; MESSENGER RNA; PERFORIN; TUMOR NECROSIS FACTOR; MONOCLONAL ANTIBODY; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CHAGAS DISEASE; CONTROLLED STUDY; FEMALE; HEART MUSCLE; HISTOPATHOLOGY; IMMUNOPATHOLOGY; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN TARGETING; SPLEEN; TRYPANOSOMA CRUZI; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; DRUG EFFECTS; FLOW CYTOMETRY; HEART; HEART DISEASES; IMMUNOHISTOCHEMISTRY; METABOLISM; PARASITOLOGY; PATHOGENICITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTIBODIES, MONOCLONAL; CHAGAS DISEASE; FEMALE; FLOW CYTOMETRY; HEART; HEART DISEASES; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-10; INTERLEUKIN-17; MICE; MICE, INBRED C57BL; NITRIC OXIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRYPANOSOMA CRUZI; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84923170887     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/798078     Document Type: Article

References (49)

1. R. C. Ferreira, B. M. Ianni, L. C. J. Abel et al. , "Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/" indeterminate" and Chagas disease cardiomyopathy patients, " Memorias do Instituto Oswaldo Cruz, vol. 98, no. 3, pp. 407-411, 2003.
2. R. Perez-Fuentes, J. F. Guegan, C. Barnabe et al. , "Severity of chronic Chagas disease is associated with cytokine/antioxidant imbalance in chronically infected individuals, " International Journal for Parasitology, vol. 33, no. 3, pp. 293-299, 2003.
3. A. Talvani, M. O. C. Rocha, A. L. Ribeiro, R. Correa-Oliveira, and M. M. Teixeira, "Chemokine receptor expression on the surface of peripheral blood mononuclear cells in Chagas disease, " Journal of Infectious Diseases, vol. 189, no. 2, pp. 214-220, 2004.
4. A. R. Perez, S. D. Silva-Barbosa, L. R. Berbert et al. , "Immunoneuroendocrine alterations in patients with progressive forms of chronic Chagas disease, " Journal of Neuroimmunology, vol. 235, no. 1-2, pp. 84-90, 2011.
5. G. R. Sousa, J. A. Gomes, R. C. Fares et al. , "Plasma cytokine expression is associated with cardiac morbidity in Chagas disease, " PLoS ONE, vol. 9, no. 3, Article ID e87082, 2014.
6. A. Rassi Jr. , A. Rassi, and J. A. Marin-Neto, "Chagas disease, " The Lancet, vol. 375, no. 9723, pp. 1388-1402, 2010.
7. L. C. J. Abel, L. V. Rizzo, B. Ianni et al. , "Chronic Chagas disease cardiomyopathy patients display an increased IFN-γ response to Trypanosoma cruzi infection, " Journal of Autoimmunity, vol. 17, no. 1, pp. 99-107, 2001.
8. D. B. Rocha Rodrigues, M. A. dos Reis, A. Romano et al. , "In situ expression of regulatory cytokines by heart inflammatory cells in Chagas disease patients with heart failure. , " Clinical and developmental immunology, vol. 2012, Article ID 361730, 7 pages, 2012.
9. K. Sliwa, A. Woodiwiss, V. N. Kone et al. , "Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline: results of a randomized study, " Circulation, vol. 109, no. 6, pp. 750-755, 2004.
10. M. Wong, D. Ziring, Y. Korin et al. , "TNFα blockade in human diseases: mechanisms and future directions, " Clinical Immunology, vol. 126, no. 2, pp. 121-136, 2008.
11. P. C. Taylor, "Pharmacology of TNF rheumatoid arthritis and other chronic inflammatory, " CurrentOpinion in Pharmacology, vol. 10, no. 3, pp. 308-315, 2010.
12. K. Kroll-Palhares, J. C. Silverio, A. A. Da Silva et al. , "TNF/TNFR1 signaling up-regulates CCR5 expression by CD8+ T lymphocytes and promotes heart tissue damage during Trypanosoma cruzi infection: beneficial effects of TNF-α blockade, " Memorias do Instituto Oswaldo Cruz, vol. 103, no. 4, pp. 375-385, 2008.
13. J. C. S. Aliberti, J. T. Souto, A. P. M. P. Marino et al. , "Modulation of chemokine production and inflammatory responses in IFN-γ and TNF-R1 deficient mice during Trypanosoma cruzi infection, " American Journal of Pathology, vol. 158, no. 4, pp. 1433-1440, 2001.
14. J. Lannes-Vieira, I. R. Pereira, N. F. Vinagre, and L. E. A. Arnez, "TNF-α and TNFR in chagas disease: from protective immunity to pathogenesis of chronic cardiomyopathy, " Advances in Experimental Medicine and Biology, vol. 691, pp. 221-230, 2011.
15. A. M. B. Bilate, V. M. Salemi, F. J. Ramires et al. , "TNF blockade aggravates experimental chronic Chagas disease cardiomyopathy, " Microbes and Infection, vol. 9, no. 9, pp. 1104-1113, 2007.
16. A. R. Perez, G. H. Fontanella, A. L. Nocito, S. Revelli, and O. A. Bottasso, "Short treatment with the tumour necrosis factor-α blocker infliximab diminishes chronic chagasic myocarditis in rats without evidence of Trypanosoma cruzi reactivation, " Clinical and Experimental Immunology, vol. 157, no. 2, pp. 291-299, 2009.
17. P. E. A. Souza, M. O. C. Rocha, E. Rocha-Vieira et al. , "Monocytes from patients with indeterminate and cardiac forms of Chagas disease display distinct phenotypic and functional characteristics associated with morbidity, " Infection and Immunity, vol. 72, no. 9, pp. 5283-5291, 2004.
18. J. C. Silverio, I. R. Pereira, M. D. C. Cipitelli et al. , "CD8+ Tcells expressing interferon gamma or perforin play antagonistic roles in heart injury in experimental trypanosoma cruzi-elicited cardiomyopathy, " PLoS Pathogens, vol. 8, no. 4, Article ID e1002645, 2012.
19. H. Bruns, C. Meinken, P. Schauenberg et al. , "Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans, " Journal of Clinical Investigation, vol. 119, no. 5, pp. 1167-1177, 2009.
20. L. Xueyi, C. Lina, W. Zhenbiao, H. Qing, L. Qiang, and P. Zhu, "Levels of circulating Th17 cells and regulatory T cells in ankylosing spondylitis patients with an inadequate response to anti-TNF-α therapy. , " Journal of clinical immunology, vol. 33, no. 1, pp. 151-161, 2013.
21. G. Vilar-Pereira, A. A. D. Silva, I. R. Pereira et al. , "Trypanosoma cruzi-induced depressive-like behavior is independent of meningoencephalitis but responsive to parasiticide and TNF-targeted therapeutic interventions, " Brain, Behavior, and Immunity, vol. 26, no. 7, pp. 1136-1149, 2012.
22. K. Redlich, S. Hayer, A. Maier et al. , "Tumor necrosis factor α-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin, " Arthritis and Rheumatism, vol. 46, no. 3, pp. 785-792, 2002.
23. C. M. E. Carvalho, J. C. Silverio, A. A. da Silva et al. , "Inducible nitric oxide synthase in heart tissue and nitric oxide in serumof Trypanosoma cruzi-infected rhesusmonkeys: Association with heart injury, " PLoS Neglected Tropical Diseases, vol. 6, no. 5, Article ID e1644, 2012.
24. G. A. Medeiros, J. C. Silverio, A. P. M. P. Marino et al. , "Treatment of chronically Trypanosoma cruzi-infected mice with a CCR1/CCR5 antagonist (Met-RANTES) results in amelioration of cardiac tissue damage, " Microbes and Infection, vol. 11, no. 2, pp. 264-273, 2009.
25. I. R. Pereira, G. Vilar-Pereira, A. A. Silva, and J. Lannes-Vieira, "Severity of chronic experimental Chagas heart disease parallels tumour necrosis factor and nitric oxide levels in the serum: models of mild and severe disease, " Memorias do Instituto Oswaldo Cruz, vol. 109, no. 3, pp. 289-298, 2014.
26. A. Talvani, C. S. Ribeiro, J. C. S. Aliberti et al. , "Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-γ as important determinants of chemokinemRNA expression during infection with Trypanosoma cruzi, " Microbes and Infection, vol. 2, no. 8, pp. 851-866, 2000.
27. C. Truyens, F. Torrico, R. Lucas, P. de Baetselier, W. A. Buurman, and Y. Carlier, "The endogenous balance of soluble tumor necrosis factor receptors and tumor necrosis factor modulates cachexia and mortality in mice acutely infected with Trypanosoma cruzi, " Infection and Immunity, vol. 67, no. 11, pp. 5579-5586, 1999.
28. P. Minoprio, "Parasite polyclonal activators: new targets for vaccination approaches?" International Journal for Parasitology, vol. 31, no. 5-6, pp. 588-591, 2001.
29. M. D. L. Higuchi, L. A. Benvenuti, M. M. Reis, and M. Metzger, "Pathophysiology of the heart in Chagas'disease: current status and new developments, " Cardiovascular Research, vol. 60, no. 1, pp. 96-107, 2003.
30. P. V. A. dos Santos, E. Roffe, H. C. Santiago et al. , "Prevalence of CD8+ αβ T cells in Trypanosoma cruzi-elicited myocarditis is associated with acquisition of CD62L Law LFA-1highVLA-4 high activation phenotype and expression of IFN-γ-inducible adhesion and chemoattractant molecules, " Microbes and Infection, vol. 3, no. 12, pp. 971-984, 2001.
31. F. S. Machado, G. A. Martins, J. C. S. Aliberti, F. L. A. C. Mestriner, F. Q. Cunha, and J. S. Silva, "Trypanosoma cruziinfected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity, " Circulation, vol. 102, no. 24, pp. 3003-3008, 2000.
32. C. Junqueira, B. Caetano, D. C. Bartholomeu et al. , "Theendless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease, " Expert Reviews in Molecular Medicine, vol. 12, article e29, 2010.
33. V. Michailowsky, N. M. Silva, C. D. Rocha, L. Q. Vieira, J. Lannes-Vieira, and R. T. Gazzinelli, "Pivotal role of interleukin-12 and interferon-γ axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection, " The American Journal of Pathology, vol. 159, no. 5, pp. 1723-1733, 2001.
34. G. Chen and D. V. Goeddel, "TNF-R1 signaling: a beautiful pathway, " Science, vol. 296, no. 5573, pp. 1634-1635, 2002.
35. E. Castanos-Velez, S. Maerlan, L. M. Osorio et al. , "Trypanosoma cruzi infectionintumor necrosis factor receptor p55-deficient mice, " Infection and Immunity, vol. 66, no. 6, pp. 2960-2968, 1998.
36. A. M. Feldman and D. McNamara, "Myocarditis, " The New England Journal of Medicine, vol. 343, no. 19, pp. 1388-1398, 2000.
37. T. Hamid, Y. Gu, R. V. Ortines et al. , "Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-αB and inflammatory activation, " Circulation, vol. 119, no. 10, pp. 1386-1397, 2009.
38. G. S. Ashcroft, M. J. Jeong, J. J. Ashworth et al. , "Tumor necrosis factor-alpha (TNF-α) is a therapeutic target for impaired cutaneous wound healing, " Wound Repair and Regeneration, vol. 20, no. 1, pp. 38-49, 2012.
39. P. M. M. Guedes, V. M. Veloso, L. C. C. Afonso et al. , "Development of chronic cardiomyopathy in canine Chagas disease correlates with high IFN-γ, TNF-α, and low IL-10 production during the acute infection phase, " Veterinary Immunology and Immunopathology, vol. 130, no. 1-2, pp. 43-52, 2009.
40. D. M. Vitelli-Avelar, R. Sathler-Avelar, A. Teixeira-Carvalho et al. , "Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease, " Scandinavian Journal of Immunology, vol. 68, no. 5, pp. 516-525, 2008.
41. Y. Iwakura, H. Ishigame, S. Saijo, and S. Nakae, "Functional specialization of interleukin-17 familymembers, " Immunity, vol. 34, no. 2, pp. 149-162, 2011.
42. A. S. Wareham, J. A. Tree, and P. D. Marsh, "Th17 cells and iron homeostasis in protective immunity against tuberculosis in cynomolgus macaques, " PLoS ONE, vol. 9, no. 2, Article ID e88149, 2014.
43. P. M. da Matta Guedes, F. R. S. Gutierrez, F. L. Maia et al. , "IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis. , " PLoS Neglected Tropical Diseases, vol. 4, no. 2, article e604, 2010.
44. J. Hartupee, C. Liu, M. Novotny, X. Li, and T. Hamilton, "IL-17 enhances chemokine gene expression through mRNA stabilization, " Journal of Immunology, vol. 179, no. 6, pp. 4135-4141, 2007.
45. E. Roffe, A. G. Rothfuchs, H. C. Santiago et al. , "IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection, " Journal of Immunology, vol. 188, no. 2, pp. 649-660, 2012.
46. R. Correa-Oliveira, J. Gomes, and E. M. Lemos, "The role of the immune response on the development of severe clinical forms of humanChagas disease, " Memorias do InstitutoOswaldo Cruz, vol. 94, supplement 1, pp. 235-253, 1999.
47. D. G. Strauss, S. Cardoso, J. A. C. Lima, C. E. Rochitte, and K. C. Wu, "ECG scar quantification correlates with cardiac magnetic resonance scar size and prognostic factors in Chagas disease, " Heart, vol. 97, no. 5, pp. 357-361, 2011.
48. S. G. Andrade, J. B. Magalhaes, and A. L. Pontes, "Therapy of the chronic phase of the experimental infection by Trypanosoma cruzi with benzonidazole and nifurtimox, "Revista da Sociedade Brasileira de Medicina Tropical, vol. 22, no. 3, pp. 113-118, 1989.
49. M. de Lourdes Higuchi, S. Fukasawa, T. de Brito, L. C. Parzianello, G. Bellotti, and J. A. F. Ramires, "Different microcirculatory and interstitial matrix patterns in idiopathic dilated cardiomyopathy and Chagas'disease: a three dimensional confocal microscopy study, " Heart, vol. 82, no. 3, pp. 279-285, 1999.